ATE107506T1 - Antiretroviraler castanosperminester. - Google Patents
Antiretroviraler castanosperminester.Info
- Publication number
- ATE107506T1 ATE107506T1 AT88115778T AT88115778T ATE107506T1 AT E107506 T1 ATE107506 T1 AT E107506T1 AT 88115778 T AT88115778 T AT 88115778T AT 88115778 T AT88115778 T AT 88115778T AT E107506 T1 ATE107506 T1 AT E107506T1
- Authority
- AT
- Austria
- Prior art keywords
- castanosperminester
- antiretroviral
- aids
- arc
- useful
- Prior art date
Links
- 230000000798 anti-retroviral effect Effects 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 206010038997 Retroviral infections Diseases 0.000 abstract 1
- DWBDMLGCCJIACZ-ODXJTPSBSA-N [(1s,6s,7s,8r,8ar)-1,7,8-trihydroxy-1,2,3,5,6,7,8,8a-octahydroindolizin-6-yl] benzoate Chemical class O([C@H]1CN2CC[C@@H]([C@@H]2[C@@H](O)[C@@H]1O)O)C(=O)C1=CC=CC=C1 DWBDMLGCCJIACZ-ODXJTPSBSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/102,070 US5004746A (en) | 1987-09-29 | 1987-09-29 | Anti-retroviral castanospermine esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE107506T1 true ATE107506T1 (de) | 1994-07-15 |
Family
ID=22287973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88115778T ATE107506T1 (de) | 1987-09-29 | 1988-09-26 | Antiretroviraler castanosperminester. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5004746A (de) |
| EP (1) | EP0309952B1 (de) |
| JP (1) | JP2761898B2 (de) |
| KR (1) | KR960009416B1 (de) |
| AT (1) | ATE107506T1 (de) |
| AU (1) | AU614993B2 (de) |
| DE (1) | DE3850335T2 (de) |
| DK (1) | DK172788B1 (de) |
| ES (1) | ES2058201T3 (de) |
| IE (1) | IE64311B1 (de) |
| PH (1) | PH24431A (de) |
| ZA (1) | ZA887160B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63501925A (ja) * | 1985-12-23 | 1988-08-04 | フレツド ハツチンソン キヤンサ− リサ−チ センタ− | レトロウイルスの複製、感染及び疾病誘発の制御 |
| US4952585A (en) * | 1988-12-15 | 1990-08-28 | Merrell Dow Pharmaceuticals Inc. | Castanospermine esters in the inhibition of tumor metastasis |
| US5214050A (en) * | 1989-10-17 | 1993-05-25 | Merrell Dow Pharmaceuticals Inc. | Esters of castanospermine in the treatment of cerebral malaria |
| ZA908134B (en) * | 1989-10-17 | 1991-07-31 | Merrell Dow Pharma | Esters of castanosperime in the treatment of cerebral malaria |
| GB8924292D0 (en) * | 1989-10-27 | 1989-12-13 | Novalal Ltd | The production of a novel dimer chemical product"novo dimers"by the polymersation of indolizidine alkaloids using cyclo dextrin glucosyl transferase |
| US5028614A (en) * | 1990-03-30 | 1991-07-02 | Merrell Dow Pharmaceuticals Inc. | Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors |
| GB9027433D0 (en) * | 1990-12-18 | 1991-02-06 | Merrell Dow Pharma | Anti-herpes castanospermine esters |
| US5939430A (en) * | 1993-02-22 | 1999-08-17 | Merrell Pharmaceuticals Inc. | Combinations of retroviral inhibitors |
| GB9303518D0 (en) * | 1993-02-22 | 1993-04-07 | Merrell Dow Pharma | Combinations of retroviral inhibitors |
| IT1269862B (it) * | 1994-05-30 | 1997-04-15 | Indena Spa | Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono |
| US5959111A (en) * | 1997-05-22 | 1999-09-28 | Hoechst Marion Roussel, Inc. | Process for preparing 6-0-monoesters of castanospermine |
| JP2002502374A (ja) * | 1997-05-22 | 2002-01-22 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | カスタノスペルミンの６−ｏ−モノエステルの製造法 |
| GB0110832D0 (en) * | 2001-05-03 | 2001-06-27 | Virogen Ltd | Antiviral compounds |
| WO2006085141A2 (en) * | 2004-08-13 | 2006-08-17 | Migenix Inc. | Compositions and methods for treating or preventing hepadnaviridae infection |
| JP2008515816A (ja) * | 2004-10-06 | 2008-05-15 | ミジェニックス インコーポレイテッド | カスタノスペルミンを含有する、併用抗ウイルス組成物およびその使用方法 |
| US20080138351A1 (en) * | 2006-08-02 | 2008-06-12 | United Therapeutics Corporation | Liposome treatment of viral infections |
| US20090252785A1 (en) * | 2008-03-26 | 2009-10-08 | University Of Oxford | Endoplasmic reticulum targeting liposomes |
| CN102427804A (zh) * | 2009-03-27 | 2012-04-25 | 牛津大学之校长及学者 | 降低胆固醇水平的脂质体 |
| EP4106752A4 (de) | 2020-02-21 | 2024-03-20 | Florida State University Research Foundation, Inc. | Behandlung von infektionen mit dem humanen coronavirus unter verwendung von alpha-glucosidase-glykoprotein-prozessierungsinhibitoren |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63501925A (ja) * | 1985-12-23 | 1988-08-04 | フレツド ハツチンソン キヤンサ− リサ−チ センタ− | レトロウイルスの複製、感染及び疾病誘発の制御 |
| ZA883925B (en) * | 1987-06-08 | 1989-02-22 | Merrell Dow Pharma | Inhibitors of glycoprotein processing having anti-retroviral activity |
| CA1315276C (en) * | 1987-07-02 | 1993-03-30 | Paul S. Liu | Castanospermine esters and glycosides |
| US4952585A (en) * | 1988-12-15 | 1990-08-28 | Merrell Dow Pharmaceuticals Inc. | Castanospermine esters in the inhibition of tumor metastasis |
-
1987
- 1987-09-29 US US07/102,070 patent/US5004746A/en not_active Expired - Lifetime
-
1988
- 1988-09-23 ZA ZA887160A patent/ZA887160B/xx unknown
- 1988-09-26 AU AU22802/88A patent/AU614993B2/en not_active Ceased
- 1988-09-26 ES ES88115778T patent/ES2058201T3/es not_active Expired - Lifetime
- 1988-09-26 DE DE3850335T patent/DE3850335T2/de not_active Expired - Fee Related
- 1988-09-26 EP EP88115778A patent/EP0309952B1/de not_active Expired - Lifetime
- 1988-09-26 AT AT88115778T patent/ATE107506T1/de not_active IP Right Cessation
- 1988-09-27 JP JP63239891A patent/JP2761898B2/ja not_active Expired - Fee Related
- 1988-09-28 IE IE293388A patent/IE64311B1/en not_active IP Right Cessation
- 1988-09-28 KR KR88012544A patent/KR960009416B1/ko not_active Expired - Fee Related
- 1988-09-28 DK DK198805388A patent/DK172788B1/da not_active IP Right Cessation
- 1988-09-29 PH PH37614A patent/PH24431A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2058201T3 (es) | 1994-11-01 |
| EP0309952A3 (en) | 1990-09-26 |
| ZA887160B (en) | 1989-05-30 |
| JP2761898B2 (ja) | 1998-06-04 |
| AU2280288A (en) | 1989-04-06 |
| DK538888A (da) | 1989-03-30 |
| KR890004701A (ko) | 1989-05-09 |
| JPH01106821A (ja) | 1989-04-24 |
| DK538888D0 (da) | 1988-09-28 |
| US5004746A (en) | 1991-04-02 |
| AU614993B2 (en) | 1991-09-19 |
| DK172788B1 (da) | 1999-07-19 |
| IE64311B1 (en) | 1995-07-26 |
| PH24431A (en) | 1990-06-25 |
| KR960009416B1 (en) | 1996-07-19 |
| DE3850335D1 (de) | 1994-07-28 |
| DE3850335T2 (de) | 1994-10-13 |
| EP0309952A2 (de) | 1989-04-05 |
| IE882933L (en) | 1989-03-29 |
| EP0309952B1 (de) | 1994-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3850335D1 (de) | Antiretroviraler Castanosperminester. | |
| FI952302L (fi) | Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa | |
| DK441786D0 (da) | Nucleosider, der kan anvendes terapeutisk | |
| GR880100248A (el) | Ουσιες για την προφυλαξη και θεραπεια ρετροιογενην φλεγμωνων. | |
| FI942112L (fi) | AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita | |
| FI893962A7 (fi) | HIV-proteaasi-inhibiittoreita, jotka ovat hyödyllisiä AIDS:in hoidossa | |
| FI862011A0 (fi) | Terapeutiska nukleosider. | |
| EP0706373A4 (de) | In liposomen verkapseltes taxol und verwendungsverfahren | |
| DE3851121D1 (de) | Filamentlose Magnetron-Ionenquelle und Verwendungsverfahren. | |
| PT87039A (pt) | Treatment of human viral infections by dsrna combined with viral inhibitors | |
| EP0296573A3 (en) | Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions | |
| FI935777L (fi) | AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit | |
| DK177888D0 (da) | Terapeutiske nukleosider | |
| EP0295538A3 (de) | Inhibitoren der Glykoprotein-Verarbeitung mit anti-retroviraler Aktivität | |
| FI883940A7 (fi) | Uusia HIV-proteiineja, jotka ovat käyttökelpoisia diagnostisoitaessa, ennakolta ehkäistäessä ja hoidettaessa AIDS-sairautta | |
| FI932847A0 (fi) | HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids | |
| DK0492841T3 (da) | Anti-herpes-castanosperminestere | |
| DE69004451D1 (de) | Prophylaxe und Behandlung von Herpesvirus-Infektionen. | |
| FI830523A0 (fi) | Anti-inflammatoriska och/eller smaerta lindrande 2,3-diaryl-5-halotiofener | |
| FI851365A0 (fi) | Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel. | |
| FI890810A7 (fi) | Palovammojen käsittely | |
| DE69015411D1 (de) | 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS. | |
| NO900616D0 (no) | Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale. | |
| GR880100196A (el) | Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους | |
| ATE76418T1 (de) | Oberflaechenbehandlung von polyolefinformkoerpern. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |